期刊文献+

慢性病毒性肝炎重症化倾向期中西医结合诊疗方案临床疗效研究 被引量:1

Clinical Study of Integrated Chinese and Western Medicine Treatment of Chronic Severe Viral Hepatitis Tendency Period
下载PDF
导出
摘要 目的:明确慢性病毒性肝炎重症化倾向期中西医结合诊疗方案的临床治疗效果,为进一步优化中西医结合诊疗方案提供临床支持。方法:采用随机、临床对照研究,将56例慢性病毒性肝炎重症化倾向期患者随机分为对照组(28例)和治疗组(28例),对照组予西医综合治疗,治疗组在西医综合治疗的基础上结合中医辨证治疗。在治疗前后观察2组患者的症状积分、肝功能指标、肝衰竭转化及不良反应情况。结果:慢性病毒性肝炎重症化倾向期患者在西医综合治疗的基础上结合中医辨证治疗,能显著改善患者症状积分,促进肝功能的恢复,减少病情向肝衰竭中、重度发展,临床总有效率优于对照组。结论:慢性病毒性肝炎重症化倾向期中西医结合诊疗方案能更全面地发挥中医药治疗重症化倾向期患者的治疗作用,且具有费用低、安全性高等优势,值得临床推广。 Ohjective:To determine the tendency of severe chronic viral midterm clinical outcomes, providing clinical support for the further optimization of integrative medicine program. Methods: A randomized, controlled clinical study was carried out. 56 patients with severe chronic tendency of viral hepatitis were randomly divided into control group ( 28 eases )and treatment group ( 28 cases )and control group used Western medicine and treatment group combined therapy. We observed symptom scores before and after treatment, liver function, liver failure and adverse reactions transtormation in two groups. Results : TCM and Western medicine treatment for viral severe tendency of patients with chronic viral midterm t:an significantly improve patients' symptom scores, and promote the recovery of liver function, reduce disease to liver failure, severe development and clinical total optimization efficieney. Conclusion : Severe chronic viral tendeney midterm :integrative treatment program can play a fuller treatment of severe tendency and has low cost, high security and other advantages, and is worthy of promotion.
出处 《辽宁中医药大学学报》 CAS 2014年第7期115-117,共3页 Journal of Liaoning University of Traditional Chinese Medicine
基金 广西科学研究与技术开发计划项目(桂科攻0816004-42)
关键词 慢性病毒性肝炎重症化倾向期 中西医结合诊疗方案 临床疗效 tendency of severe chronic viral hepatitis integrative treatment program clinical efficacy
  • 相关文献

参考文献3

  • 1中华医学会传染病与寄生虫病学分会 肝病学分会.病毒性肝炎防治方案.肝脏,5:257-263.
  • 2郑筱萸.中药新药临床研究指导原则[S].北京:中国医药科技出版社.2004:58.
  • 3李树龙,姜颖,贺福初.乙型肝炎免疫发病机制研究进展[J].军事医学科学院院刊,2006,30(6):580-583. 被引量:8

二级参考文献27

  • 1Guidotti LG,Chisari FV.Noncytolytic control of viral infections by the innate and adaptive immune response[J].Annu Rev Immunol,2001,19:65-91.
  • 2Guidotti LG,Ishikawa T,Hobbs MV,et al.Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes[J].Immunity,1996,4(1):25-36.
  • 3Rehermann B,Nascimbeni M.Immunology of hepatitis B virus and hepatitis C virus infection[J].Nat Rev Immunol,2005,5(3):215-229.
  • 4Monsalve-De Castillo F,Romero TA,Estevez J,et al.Concentrations of cytokines,soluble interleukin-2 receptor,and soluble CD30 in sera of patients with hepatitis B virus infection during acute and convalescent phases[J].Clin Diagn Lab Immunol,2002,9(6):1372-1375.
  • 5Guidotti LG,Rochford R,Chung J,et al.Viral clearance without destruction of infected cells during acute HBV infection[J].Science,1999,284(5415):825-829.
  • 6Kakimi K.Recent advance in the study of immunopathobiology of hepatitis B virus infection using HBV transgenic mice[J].Nippon Rinsho,2004,62 (Suppl 8):54-57.
  • 7Sobao Y,Tomiyama H,Sugi K,et al.The role of hepatitis B virus-specific memory CD8 T cells in the control of viral replication[J].J Hepatol,2002,36(1):105-115.
  • 8Chisari FV,Ferrari C.Hepatitis B virus immunopathogenesis[J].Annu Rev Immunol,1995,13(1):29-60.
  • 9Stephan W,Prince AM,Brotman B.Modulation of hepatitis B infection by intravenous application of an immunoglobulin preparation that contains antibodies to hepatitis B e and core antigens but not to hepatitis B surface antigen[J].J Virol,1984,51(2):420-424.
  • 10Parker DC.T cell-dependent B cell activation[J].Annu Rev Immunol,1993,11:331-360.

共引文献73

同被引文献17

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部